Latest Insider Transactions at Broadridge Financial Solutions, Inc. (BR)
This section provides a real-time view of insider transactions for Broadridge Financial Solutions, Inc. (BR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BROADRIDGE FINANCIAL SOLUTIONS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BROADRIDGE FINANCIAL SOLUTIONS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2025
|
Douglas Richard Deschutter Co-President ICS |
SELL
Open market or private sale
|
Direct |
5,056
-19.28%
|
$1,208,384
$239.55 P/Share
|
|
May 20
2025
|
Pamela L Carter Director |
SELL
Open market or private sale
|
Direct |
4,829
-22.34%
|
$1,168,618
$242.23 P/Share
|
|
May 20
2025
|
Pamela L Carter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,908
+24.77%
|
$676,984
$98.09 P/Share
|
|
May 15
2025
|
Hope M. Jarkowski Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,069
-99.91%
|
$256,560
$240.99 P/Share
|
|
May 13
2025
|
Thomas P Carey Corporate VP |
SELL
Open market or private sale
|
Direct |
3,607
-37.25%
|
$854,859
$237.26 P/Share
|
|
May 07
2025
|
Hope M. Jarkowski Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,068
-49.95%
|
$250,980
$235.22 P/Share
|
|
May 07
2025
|
Richard John Stingi Corporate VP and CHRO |
SELL
Open market or private sale
|
Direct |
800
-12.68%
|
$187,200
$234.81 P/Share
|
|
Apr 07
2025
|
Thomas P Carey Corporate VP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,462
-20.27%
|
-
|
|
Apr 03
2025
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.35%
|
-
|
|
Apr 03
2025
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.32%
|
-
|
|
Apr 03
2025
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.14%
|
-
|
|
Apr 03
2025
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.11%
|
-
|
|
Apr 03
2025
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.15%
|
-
|
|
Apr 03
2025
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.09%
|
-
|
|
Apr 03
2025
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.36%
|
-
|
|
Apr 03
2025
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.17%
|
-
|
|
Apr 02
2025
|
Timothy C Gokey CEO |
SELL
Open market or private sale
|
Direct |
11,724
-7.57%
|
$2,872,380
$245.07 P/Share
|
|
Apr 01
2025
|
Richard J Daly Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-0.58%
|
$147,376
$244.72 P/Share
|
|
Apr 01
2025
|
Douglas Richard Deschutter Co-President ICS |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-3.37%
|
$223,016
$244.72 P/Share
|
|
Apr 01
2025
|
Ashima Ghei Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-6.6%
|
$220,576
$244.72 P/Share
|
|
Apr 01
2025
|
Ashima Ghei Interim CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,304
+12.33%
|
-
|
|
Apr 01
2025
|
Timothy C Gokey CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,000
-8.83%
|
$3,660,000
$244.72 P/Share
|
|
Apr 01
2025
|
Hope M. Jarkowski Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,766
-45.24%
|
$430,904
$244.72 P/Share
|
|
Apr 01
2025
|
Hope M. Jarkowski Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,903
+49.99%
|
-
|
|
Apr 01
2025
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-3.92%
|
$63,196
$244.72 P/Share
|
|
Apr 01
2025
|
Christopher John Perry President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,155
-7.91%
|
$1,013,820
$244.72 P/Share
|
|
Apr 01
2025
|
Richard John Stingi Corporate VP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,732
-11.41%
|
$422,608
$244.72 P/Share
|
|
Apr 01
2025
|
Richard John Stingi Corporate VP and CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,511
+15.82%
|
-
|
|
Mar 19
2025
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
131
+0.83%
|
-
|
|
Mar 19
2025
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
147
+0.51%
|
-
|
|
Mar 19
2025
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
131
+1.57%
|
-
|
|
Mar 19
2025
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
181
+5.16%
|
-
|
|
Mar 19
2025
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
131
+1.71%
|
-
|
|
Mar 10
2025
|
Timothy C Gokey CEO |
SELL
Open market or private sale
|
Direct |
95,956
-13.57%
|
$22,549,660
$235.42 P/Share
|
|
Mar 10
2025
|
Timothy C Gokey CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
59,395
+18.27%
|
$3,979,465
$67.32 P/Share
|
|
Mar 07
2025
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
22,357
-11.13%
|
$5,253,895
$235.23 P/Share
|
|
Mar 07
2025
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
24,644
+11.01%
|
$3,573,380
$145.86 P/Share
|
|
Feb 27
2025
|
Robert N Duelks Director |
SELL
Open market or private sale
|
Indirect |
485
-8.91%
|
$114,945
$237.93 P/Share
|
|
Feb 26
2025
|
Robert N Duelks Director |
SELL
Open market or private sale
|
Direct |
8,405
-8.76%
|
$1,991,985
$237.15 P/Share
|
|
Feb 26
2025
|
Robert N Duelks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,631
+14.01%
|
$1,009,539
$69.97 P/Share
|
|
Feb 06
2025
|
Brett Keller Director |
SELL
Open market or private sale
|
Direct |
5,442
-13.81%
|
$1,306,080
$240.4 P/Share
|
|
Feb 06
2025
|
Brett Keller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,858
+18.61%
|
$469,474
$53.9 P/Share
|
|
Feb 04
2025
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Open market or private sale
|
Direct |
514
-7.22%
|
$123,874
$241.6 P/Share
|
|
Jan 03
2025
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.38%
|
-
|
|
Jan 03
2025
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
67
+0.12%
|
-
|
|
Jan 03
2025
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.37%
|
-
|
|
Jan 03
2025
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.37%
|
-
|
|
Jan 03
2025
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.18%
|
-
|
|
Jan 03
2025
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
-
|
|
Jan 03
2025
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.18%
|
-
|